Eosinophilic Gastrointestinal Disease Program | Research and Innovation

The 325,000 square-foot Karp Family Research Building opened its doors October 2003.While we are learning more about the cause and treatment of EGIDs, a lot remains uncertain. The EGID Program at Boston Children’s Hospital is actively involved in cutting edge research with basic science, clinical and translational studies.

You may be offered the opportunity to participate in a study. Please know that while conducting research is a very important mission of our program, your child’s care in the EGID Program will never be compromised should you decline to participate.

The EGID Program is currently conducting the following clinical trials. Click each link to learn more:

  • Esophagitis Registry

  • A Prospective Case-Controlled Study to Identify Novel Biologic Markers Associated with Eosinophilic Esophagitis